Reuters
Senate Finance Committee launches probe into AbbVie’s tax practices
In a letter addressed to AbbVie’s chief executive officer, Richard Gonzalez, on Wednesday, Wyden noted that the company has consistently reported a net loss in the United States and net income overseas, despite being headquartered in the country. AbbVie is already under scrutiny for its drug pricing practices, which U.S. lawmakers questioned last month, accusing the company of profiting from Americans by repeatedly raising U.S. prices on its widely-used rheumatoid arthritis drug, Humira, while cutting prices abroad.